Your browser doesn't support javascript.
Minority Health Social Vulnerability Index and COVID-19 vaccination coverage - The United States, December 14, 2020-January 31, 2022.
Saelee, Ryan; Chandra Murthy, Neil; Patel Murthy, Bhavini; Zell, Elizabeth; Shaw, Lauren; Gibbs-Scharf, Lynn; Harris, LaTreace; Shaw, Kate M.
  • Saelee R; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States. Electronic address: eocevent534@cdc.gov.
  • Chandra Murthy N; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States; Commisioned Corps of the United State Public Health Service, United States.
  • Patel Murthy B; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States.
  • Zell E; CDC COVID-19 Response Team, United States; Stat-Epi Associates, Inc., Ponte Vedra Beach, FL, United States.
  • Shaw L; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States.
  • Gibbs-Scharf L; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States.
  • Harris L; Immunization Services Division, National Center for Immunization and Respiratory Diseases, CDC, United States; CDC COVID-19 Response Team, United States.
  • Shaw KM; Office of Science, National Center for Injury Prevention and Control, CDC, United States.
Vaccine ; 41(12): 1943-1950, 2023 03 17.
Article in English | MEDLINE | ID: covidwho-2235122
ABSTRACT

INTRODUCTION:

In 2021, HHS Office of Minority Health and CDC developed a composite measure of social vulnerability called the Minority Health Social Vulnerability Index (MHSVI) to assess the needs of communities most vulnerable to COVID-19. The MHSVI extends the CDC Social Vulnerability Index with two new themes on healthcare access and medical vulnerability. This analysis examines COVID-19 vaccination coverage by social vulnerability using the MHSVI.

METHODS:

County-level COVID-19 vaccine administration data among persons aged ≥18 years reported to CDC from 12/14/20 to 01/31/22 were analyzed. U.S. counties from 50 states and DC were categorized into tertiles of vulnerability (low, moderate, and high) for the composite MHSVI measure and each of the 34 indicators. Vaccination coverage (≥1 dose, primary series completion, and receipt of a booster dose) was calculated by tertiles for the composite MHSVI measure and each indicator.

RESULTS:

Counties with lower per capita income, higher proportion of individuals with no high school diploma, living below poverty, ≥65 years of age, with a disability, and in mobile homes had lower vaccination uptake. However, counties with larger proportions of racial/ethnic minorities and individuals speaking English less than "very well" had higher coverage. Counties with fewer primary care physicians and greater medical vulnerabilities had lower ≥ 1 dose vaccination coverage. Furthermore, counties of high vulnerability had lower primary series completion and receipt of a booster dose. There were no clear patterns in COVID-19 vaccination coverage by tertiles for the composite measure.

CONCLUSION:

Results from the new components in the MHSVI identify needs to prioritize persons in counties with greater medical vulnerabilities and limited access to health care, who are at greater risk for adverse COVID-19 outcomes. Findings suggest that using a composite measure to characterize social vulnerability might mask disparities in COVID-19 vaccination uptake that would have otherwise been observed using specific indicators.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2023 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 Type of study: Observational study / Prognostic study Topics: Vaccines Limits: Adolescent / Adult / Humans Country/Region as subject: North America Language: English Journal: Vaccine Year: 2023 Document Type: Article